447 related articles for article (PubMed ID: 10064594)
1. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta.
Yang X; Letterio JJ; Lechleider RJ; Chen L; Hayman R; Gu H; Roberts AB; Deng C
EMBO J; 1999 Mar; 18(5):1280-91. PubMed ID: 10064594
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease.
Benahmed M; Meresse B; Arnulf B; Barbe U; Mention JJ; Verkarre V; Allez M; Cellier C; Hermine O; Cerf-Bensussan N
Gastroenterology; 2007 Mar; 132(3):994-1008. PubMed ID: 17324400
[TBL] [Abstract][Full Text] [Related]
3. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.
Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y
Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953
[TBL] [Abstract][Full Text] [Related]
4. Concentration-dependent bifunctional effect of TGF-beta 1 on immunoglobulin production: a role for Smad3 in IgA production in vitro.
McKarns SC; Letterio JJ; Kaminski NE
Int Immunopharmacol; 2003 Dec; 3(13-14):1761-74. PubMed ID: 14636827
[TBL] [Abstract][Full Text] [Related]
5. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
Alvarez J; Serra R
Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
[TBL] [Abstract][Full Text] [Related]
6. Loss of Smad3 in acute T-cell lymphoblastic leukemia.
Wolfraim LA; Fernandez TM; Mamura M; Fuller WL; Kumar R; Cole DE; Byfield S; Felici A; Flanders KC; Walz TM; Roberts AB; Aplan PD; Balis FM; Letterio JJ
N Engl J Med; 2004 Aug; 351(6):552-9. PubMed ID: 15295048
[TBL] [Abstract][Full Text] [Related]
7. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
Brown KA; Pietenpol JA; Moses HL
J Cell Biochem; 2007 May; 101(1):9-33. PubMed ID: 17340614
[TBL] [Abstract][Full Text] [Related]
8. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response.
Ashcroft GS; Yang X; Glick AB; Weinstein M; Letterio JL; Mizel DE; Anzano M; Greenwell-Wild T; Wahl SM; Deng C; Roberts AB
Nat Cell Biol; 1999 Sep; 1(5):260-6. PubMed ID: 10559937
[TBL] [Abstract][Full Text] [Related]
9. Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta.
Yang YA; Tang B; Robinson G; Hennighausen L; Brodie SG; Deng CX; Wakefield LM
Cell Growth Differ; 2002 Mar; 13(3):123-30. PubMed ID: 11959813
[TBL] [Abstract][Full Text] [Related]
10. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
12. Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells.
Mithani SK; Balch GC; Shiou SR; Whitehead RH; Datta PK; Beauchamp RD
J Surg Res; 2004 Apr; 117(2):296-305. PubMed ID: 15047135
[TBL] [Abstract][Full Text] [Related]
13. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation.
Feinberg MW; Shimizu K; Lebedeva M; Haspel R; Takayama K; Chen Z; Frederick JP; Wang XF; Simon DI; Libby P; Mitchell RN; Jain MK
Circ Res; 2004 Mar; 94(5):601-8. PubMed ID: 14752027
[TBL] [Abstract][Full Text] [Related]
14. Burn-induced thymic apoptosis corresponds with altered TGF-beta(1) and Smad 2/3.
Hobson KG; Cho K; Adamson LK; Greenhalgh DG
J Surg Res; 2002 Jun; 105(1):4-9. PubMed ID: 12069494
[TBL] [Abstract][Full Text] [Related]
15. Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.
Weinstein M; Monga SP; Liu Y; Brodie SG; Tang Y; Li C; Mishra L; Deng CX
Mol Cell Biol; 2001 Aug; 21(15):5122-31. PubMed ID: 11438667
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
[TBL] [Abstract][Full Text] [Related]
17. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis.
Ito Y; Sarkar P; Mi Q; Wu N; Bringas P; Liu Y; Reddy S; Maxson R; Deng C; Chai Y
Dev Biol; 2001 Aug; 236(1):181-94. PubMed ID: 11456453
[TBL] [Abstract][Full Text] [Related]
19. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
20. Smad3 mediates TGF-beta1 induction of VEGF production in lung fibroblasts.
Kobayashi T; Liu X; Wen FQ; Fang Q; Abe S; Wang XQ; Hashimoto M; Shen L; Kawasaki S; Kim HJ; Kohyama T; Rennard SI
Biochem Biophys Res Commun; 2005 Feb; 327(2):393-8. PubMed ID: 15629128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]